Analytical Lens: Exploring Sana Biotechnology Inc (SANA)’s Financial Story Through Ratios

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Sana Biotechnology Inc (NASDAQ: SANA) was $2.42 for the day, down -6.56% from the previous closing price of $2.59. In other words, the price has decreased by -$6.56 from its previous closing price. On the day, 2.64 million shares were traded. SANA stock price reached its highest trading level at $2.65 during the session, while it also had its lowest trading level at $2.345.

Ratios:

Our analysis of SANA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.47 and its Current Ratio is at 4.47. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.29.

On June 26, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $16.

H.C. Wainwright Upgraded its Neutral to Buy on January 16, 2024, while the target price for the stock was maintained at $12.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 21 ’24 when NATHAN HARDY bought 45,796 shares for $3.95 per share.

Mulligan Richard sold 150,000 shares of SANA for $612,570 on Sep 24 ’24. The Director now owns 2,848,121 shares after completing the transaction at $4.08 per share. On Sep 25 ’24, another insider, Mulligan Richard, who serves as the Director of the company, sold 150,000 shares for $3.89 each. As a result, the insider received 583,170 and left with 2,698,121 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SANA now has a Market Capitalization of 540310976 and an Enterprise Value of 437387712.

Stock Price History:

Over the past 52 weeks, SANA has reached a high of $12.00, while it has fallen to a 52-week low of $2.55. The 50-Day Moving Average of the stock is -38.30%, while the 200-Day Moving Average is calculated to be -62.73%.

Shares Statistics:

SANA traded an average of 1.40M shares per day over the past three months and 2067680 shares per day over the past ten days. A total of 197.86M shares are outstanding, with a floating share count of 122.07M. Insiders hold about 45.33% of the company’s shares, while institutions hold 53.23% stake in the company. Shares short for SANA as of 1730332800 were 34283525 with a Short Ratio of 24.49, compared to 1727654400 on 31525620. Therefore, it implies a Short% of Shares Outstanding of 34283525 and a Short% of Float of 31.740000000000002.

Most Popular